ELCC 2019 | A STELLAR study: TTFields for malignant pleural mesothelioma

Ori Farber

In this interview, Ori Farber, MD, of Novocure, Haifa, Israel, discusses the promising results of the STELLAR study (NCT02397928) utilizing tumor treating fields (TTF) for the treatment of malignant pleural mesothelioma. This video was recorded at the European Lung Cancer Congress (ELCC) 2019, held in Geneva, Switzerland.

Share this video